This inventor holds 1 USPTO granted patent. Top assignee: Ucbbiopharma Srl. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Paul Jonathan Hickford: Innovator in IL-17 Modulation
Introduction
Paul Jonathan Hickford is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate human IL-17 activity. His work is crucial in addressing various inflammatory and autoimmune disorders.
Latest Patents
Hickford holds a patent for "Imidazopyridine derivatives as IL-17 modulators." This patent describes a series of substituted fused bicyclic imidazole derivatives, including imidazo[1,2-a]pyridine derivatives and their analogues. These compounds are recognized for their potential benefits in treating and preventing a range of human ailments.
Career Highlights
Throughout his career, Hickford has been associated with Ucbbiopharma Srl, where he has focused on innovative drug development. His expertise in medicinal chemistry has positioned him as a key player in the pharmaceutical industry.
Collaborations
Hickford has collaborated with esteemed colleagues, including Anne Marie Foley and Fabien Claude Lecomte. These partnerships have enhanced his research and contributed to the advancement of therapeutic solutions.
Conclusion
Paul Jonathan Hickford's work in developing IL-17 modulators showcases his commitment to improving human health through innovative solutions. His contributions to medicinal chemistry are invaluable and continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile